Intranasal Basic Fibroblast Growth Factor Attenuates Endoplasmic Reticulum Stress and Brain Injury in Neonatal Hypoxic-Ischaemic Injury

Zhenlang Lin,Yingying Hu,Zhouguang Wang,Shulin Pan,Hao Zhang,Libing Ye,Hongyu Zhang,Mingchu Fang,Huai Jiang,Junming Ye,Jian Xiao,Li Liu

2017-01-01

American journal of translational research

Abstract:Brain injury secondary to birth asphyxia is the major cause of death and long-term disability in newborns. Intranasal drug administration enables agents to bypass the blood-brain barrier (BBB) and enter the brain directly. In this study, we determined whether intranasal basic fibroblast growth factor (bFGF) could exert neuroprotective effects in neonatal rats after hypoxic-ischaemic (HI) brain injury and assessed whether attenuation of endoplasmic reticulum (ER) stress was associated with these neuroprotective effects. Rats were subjected to HI brain injury via unilateral carotid artery ligation followed by 2.5 h of hypoxia and then treated with intranasal bFGF or vehicle immediately after HI injury. We found that the unfolded protein response (UPR) was strongly activated after HI injury and that bFGF significantly reduced the levels of the ER stress signalling proteins GRP78 and PDI. bFGF also decreased brain infarction volumes and conferred long-term neuroprotective effects against brain atrophy and neuron loss after HI brain injury. Taken together, our results suggest that intranasal bFGF provides neuroprotection function partly by inhibiting HI injury-induced ER stress. bFGF may have potential as a therapy for human neonates after birth asphyxia.